The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback